Niraparib Shows Superior Tissue Distribution and Efficacy in a Prostate Cancer Bone Metastasis Model Compared with Other PARP Inhibitors

Linda A. Snyder, Rao N. V. S. Mamidi|Molecular Cancer Therapeutics|2022

Cited by 4